Cutaneous T-Cell Lymphoma, Relapsed
2 clinical trials · Condition
◉ Watch Cutaneous T-Cell Lymphoma, Relapsed
| Record | Firm | Date |
|---|---|---|
| Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma (NCT07535710) | Shanghai Jiao Tong University School of Medicine | 2026-03-30 |
| Mogamulizumab Q4week Dosing in Participants With R/R CTCL (NCT04745234) | Kyowa Kirin, Inc. | 2021-08-16 |
Track Cutaneous T-Cell Lymphoma, Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.